News

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
As the prospect of sector-specific tariffs under the second Trump administration continues to rattle drugmakers, a more ...
The U.S. federal government's "covid.gov" website now redirects to a White House page offering up the unproven theory that ...
US flu activity declined steadily again last week, with rates of influenza-like illness (ILI) dropping further and staying ...
US hospital data from 2018 through 2022 shows carbapenem-resistant Acinetobacter baumanii accounted for more than one third of all Acinetobacter nfections.
Leerink Partners analyst Puneet Souda maintained a Buy rating on Bio-Techne (TECH – Research Report) yesterday and set a price target of ...